
Ramesh Swaminathan
About Ramesh Swaminathan
Data last updated:
Ramesh Swaminathan is a Whole-Time Director at Lupin Limited (since 2020), Director at Lupin Manufacturing Solutions Limited (since 2023) and Director at Lupin Life Sciences Limited (since 2025), and holds 9 more current directorships. The companies operate in Pharma, Healthcare and Internet. The 5 current companies with reported revenue have a combined latest revenue of ₹29,175 Cr; the largest is Lupin Limited at ₹28,382 Cr (FY 2026). Earlier, Ramesh Swaminathan was a Director at Novodigm Limited (from 2007).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Whole-Time Director | 26 Mar 2020 | 1983 | ₹28,382 Cr (FY 2026) | Active | |
| Director | 24 Jul 2023 | 2023 | ₹435 Cr (FY 2025) | Active | |
| Director | 21 May 2025 | 2023 | ₹257 Cr (FY 2025) | Active | |
| Director | 28 Nov 2023 | 2011 | ₹98.57 Cr (FY 2025) | Active | |
| Director | 01 Sep 2021 | 2021 | ₹1.94 Cr (FY 2025) | Active | |
| Director | 08 Mar 2025 | 2025 | Active | ||
| Partner | 19 Jun 2023 | 2021 | Active | ||
| Partner | 19 Jun 2023 | 2021 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 26 Sep 2007 | 2006 | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Ramesh Swaminathan
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ramesh Swaminathan
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ramesh Swaminathan
Ramesh Swaminathan currently holds 12 directorships: Lupin Limited (Whole-Time Director, since 26 Mar 2020, revenue ₹28,382 Cr (FY 2026)); Lupin Manufacturing Solutions Limited (Director, since 24 Jul 2023, revenue ₹435 Cr (FY 2025)); Lupin Life Sciences Limited (Director, since 21 May 2025, revenue ₹257 Cr (FY 2025)); Lupin Diagnostics Limited (Director, since 28 Nov 2023, revenue ₹98.57 Cr (FY 2025)); Lupin Digital Health Limited (Director, since 01 Sep 2021, revenue ₹1.94 Cr (FY 2025)); and 7 more.
Ramesh Swaminathan was first appointed on 26 Sep 2007 as Director at Novodigm Limited. The most recent appointment on record is 21 May 2025 at Lupin Life Sciences Limited.
The 5 current companies of Ramesh Swaminathan that report revenue have a combined latest revenue of ₹29,175 Cr: Lupin Limited ₹28,382 Cr (FY 2026); Lupin Manufacturing Solutions Limited ₹435 Cr (FY 2025); Lupin Life Sciences Limited ₹257 Cr (FY 2025); Lupin Diagnostics Limited ₹98.57 Cr (FY 2025); Lupin Digital Health Limited ₹1.94 Cr (FY 2025).
Ramesh Swaminathan held 1 earlier board appointment: Novodigm Limited (Director, from 26 Sep 2007).
The current boards of Ramesh Swaminathan's companies include Alfonso Martin Gimenez Zulueta (Lupin Limited), Amit Kumar Gupta (Lupin Limited), Anand Thirumalachar Kripalu (Lupin Limited), Jeffrey Bruce Kindler (Lupin Limited), Kanwar Bir Singh Anand (Lupin Limited), Manju Deshbandhu Gupta (Lupin Limited), among others.